Oxaliplatino Sun

Oxaliplatin, the active ingredient in Oxaliplatino Sun, is a platinum-based antineoplastic agent presented as a sterile solution for intravenous use. It is employed in the treatment of colorectal cancer and other gastrointestinal malignancies in adult patients. GNH USA supplies Oxaliplatino Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres and hospitals worldwide.

GNH USA supplies Oxaliplatino Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres and hospitals worldwide.

Oxaliplatin is used primarily for colorectal cancer treatment and the following pathways or disease families: - Colon cancer: Achieves the reduction of tumor size and growth in patients with metastatic disease. - Rectal cancer : Achieves tumor shrink‑sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh sh. - Gastric cancer : Achieves control of disease progression and symptom relief in advanced cases. - Peritoneal carcinomatosis : Achieves local control when used in hyper‑hyper hyper hyper HI‑HI HI HI HI HI HI HI HI HI HI HI HI . - Adjuvant therapy : Achieves improved disease‑free survival when the treatment is given as part‑ by the the the . -  

Oxaliplatin may … 

Common Side Effects: -   -  .

t​   t  .... ...   ewline

Serious or Rare Side Effects: -   -  d  d

The  t  t.

   t \

   ewline  ullet  ....  ewline